Clarus Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2003-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
13
Active:2
Completed:11
Trial Phases
3 Phases
Phase 1:3
Phase 2:5
Phase 3:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (41.7%)Phase 3
4 (33.3%)Phase 1
3 (25.0%)Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes
- First Posted Date
- 2019-06-04
- Last Posted Date
- 2019-07-09
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT03973840
- Locations
- 🇺🇸
Clarus Therapeutics, Inc, Northbrook, Illinois, United States
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
- First Posted Date
- 2016-10-03
- Last Posted Date
- 2018-05-17
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT02921386
- Locations
- 🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States
A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3
Completed
- Conditions
- Hypogonadism
- Interventions
- First Posted Date
- 2016-03-29
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 222
- Registration Number
- NCT02722278
- Locations
- 🇺🇸
Multiple Sites in the United States, Northbrook, Illinois, United States
Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Phase 2
Completed
- Conditions
- Hypogonadism
- Interventions
- First Posted Date
- 2016-03-03
- Last Posted Date
- 2018-11-01
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02697188
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, California, United States
🇺🇸dgd Research, Inc, San Antonio, Texas, United States
Phlebotomy Study of Testosterone Undecanoate
- First Posted Date
- 2016-02-01
- Last Posted Date
- 2018-03-09
- Lead Sponsor
- Clarus Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT02670343
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute, Torrance, California, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found